Assurant Valuation
Is AIZ * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AIZ * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AIZ * (MX$3918) is trading below our estimate of fair value (MX$5318.6)
Significantly Below Fair Value: AIZ * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AIZ *?
Other financial metrics that can be useful for relative valuation.
What is AIZ *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$10.36b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.9x |
Enterprise Value/EBITDA | 8.1x |
PEG Ratio | 1.5x |
Price to Earnings Ratio vs Peers
How does AIZ *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 10.7x | ||
Q * Quálitas Controladora. de | 13.1x | 13.2% | Mex$62.3b |
GNP * Grupo Nacional Provincial | 6.6x | n/a | Mex$31.3b |
AFG American Financial Group | 12.7x | 8.1% | US$11.3b |
CNA CNA Financial | 10.3x | 8.4% | US$13.2b |
AIZ * Assurant | 13x | 8.4% | Mex$10.4b |
Price-To-Earnings vs Peers: AIZ * is expensive based on its Price-To-Earnings Ratio (13x) compared to the peer average (10.7x).
Price to Earnings Ratio vs Industry
How does AIZ *'s PE Ratio compare vs other companies in the South American Insurance Industry?
Price-To-Earnings vs Industry: AIZ * is expensive based on its Price-To-Earnings Ratio (13x) compared to the South American Insurance industry average (8.8x).
Price to Earnings Ratio vs Fair Ratio
What is AIZ *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 13x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AIZ *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$4,139.19 0% | 6.4% | Mex$4,426.53 | Mex$3,766.43 | n/a | 5 |
Sep ’25 | n/a | Mex$4,024.35 0% | 6.0% | Mex$4,332.16 | Mex$3,686.14 | n/a | 5 |
Aug ’25 | n/a | Mex$3,705.72 0% | 6.2% | Mex$3,943.76 | Mex$3,304.23 | n/a | 5 |
Jul ’25 | n/a | Mex$3,516.94 0% | 6.3% | Mex$3,756.12 | Mex$3,132.91 | n/a | 5 |
Jun ’25 | n/a | Mex$3,516.94 0% | 6.3% | Mex$3,756.12 | Mex$3,132.91 | n/a | 5 |
May ’25 | n/a | Mex$3,428.57 0% | 8.2% | Mex$3,878.92 | Mex$2,991.37 | n/a | 5 |
Apr ’25 | n/a | Mex$3,438.52 0% | 5.8% | Mex$3,670.72 | Mex$3,107.30 | n/a | 5 |
Mar ’25 | n/a | Mex$3,438.52 0% | 5.8% | Mex$3,670.72 | Mex$3,107.30 | n/a | 5 |
Feb ’25 | n/a | Mex$3,318.84 0% | 6.7% | Mex$3,532.52 | Mex$2,929.41 | n/a | 5 |
Jan ’25 | n/a | Mex$3,381.63 0% | 6.1% | Mex$3,664.03 | Mex$3,038.46 | n/a | 5 |
Dec ’24 | n/a | Mex$3,381.63 0% | 6.1% | Mex$3,664.03 | Mex$3,038.46 | n/a | 5 |
Nov ’24 | n/a | Mex$3,167.03 0% | 9.3% | Mex$3,651.52 | Mex$2,796.53 | n/a | 5 |
Oct ’24 | n/a | Mex$2,973.73 0% | 6.1% | Mex$3,224.74 | Mex$2,736.67 | n/a | 5 |
Sep ’24 | n/a | Mex$2,865.19 0% | 7.9% | Mex$3,162.65 | Mex$2,564.31 | n/a | 5 |
Aug ’24 | n/a | Mex$2,755.14 0% | 8.8% | Mex$3,119.34 | Mex$2,428.03 | n/a | 5 |
Jul ’24 | n/a | Mex$2,834.19 0% | 6.1% | Mex$3,026.46 | Mex$2,563.59 | n/a | 5 |
Jun ’24 | n/a | Mex$2,834.19 0% | 6.1% | Mex$3,026.46 | Mex$2,563.59 | n/a | 5 |
May ’24 | n/a | Mex$2,804.58 0% | 9.3% | Mex$3,068.08 | Mex$2,328.13 | n/a | 5 |
Apr ’24 | n/a | Mex$2,932.67 0% | 8.8% | Mex$3,159.40 | Mex$2,471.77 | n/a | 5 |
Mar ’24 | n/a | Mex$2,932.67 0% | 8.8% | Mex$3,159.40 | Mex$2,471.77 | n/a | 5 |
Feb ’24 | n/a | Mex$3,026.29 0% | 9.7% | Mex$3,322.46 | Mex$2,525.07 | n/a | 5 |
Jan ’24 | n/a | Mex$3,139.30 0% | 9.6% | Mex$3,459.56 | Mex$2,629.26 | n/a | 5 |
Dec ’23 | n/a | Mex$3,144.73 0% | 7.8% | Mex$3,448.03 | Mex$2,758.42 | n/a | 6 |
Nov ’23 | n/a | Mex$3,676.14 0% | 10.5% | Mex$4,287.72 | Mex$3,091.15 | n/a | 6 |
Oct ’23 | n/a | Mex$3,987.42 0% | 9.8% | Mex$4,430.47 | Mex$3,222.16 | n/a | 6 |
Sep ’23 | n/a | Mex$4,010.63 0% | 9.8% | Mex$4,456.25 | Mex$3,240.91 | n/a | 6 |
Analyst Forecast: Target price is less than 20% higher than the current share price.